ARJUN TARAKAD to Glucagon-Like Peptide-1 Receptor
This is a "connection" page, showing publications ARJUN TARAKAD has written about Glucagon-Like Peptide-1 Receptor.
Connection Strength
0.054
-
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2024 01; 23(1):37-45.
Score: 0.054
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.